Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of EDS-FLU on Eustachian Tube Dysfunction
NCT05275686Phase 2Recruiting
- Sponsor
- Cedars-Sinai Medical Center
- Start
- Apr 2022
- Primary completion
- Jun 2027
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of fluticasone propionate nasal spray in Eustachian tube dysfunction (ETD), sponsored by Cedars-Sinai Medical Center. Started Apr 2022; status: recruiting.
02
Drugs
fluticasone propionate nasal spray
03
Conditions
Eustachian tube dysfunction (ETD)
Beyond the preview
Go deeper on NCT05275686.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05275686.